Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.

OBJECTIVE: To characterize the magnitude and the predictors of highly active antiretroviral therapy (HAART) interruption (TI) and to investigate its immunologic and virological consequences. METHODS: Using Concerted Action on Seroconversion to AIDS and Death in Europe data from 8,300 persons with we...

Full description

Bibliographic Details
Main Authors:	Touloumi, G, Pantazis, N, Antoniou, A, Stirnadel, H, Walker, SA, Porter, K
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
by: Touloumi, G, et al.
Published: (2008)

The immunological and virological consequences of planned treatment interruptions in children with HIV infection
by: Klein, N, et al.
Published: (2013)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
by: Mulugeta Melku, et al.
Published: (2020-08-01)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Immunological predictors of CD4<sup>+ </sup>T cell decline in antiretroviral treatment interruptions
by: Gonzalez-García Juan, et al.
Published: (2008-02-01)

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
by: Touloumi, G, et al.
Published: (2004)

Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia
by: Genet Gebrehiwet Hailu, et al.
Published: (2021-06-01)

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
by: Eugène Messou, et al.
Published: (2008-06-01)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
by: Kristen L. Bunnell PharmD, et al.
Published: (2018-01-01)

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.
by: Elkin Hernán Bermúdez-Aza, et al.
Published: (2018-01-01)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
by: Giota Touloumi, et al.
Published: (2013-01-01)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
by: Suzy Maria MD, et al.
Published: (2020-01-01)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
by: P. Zacharopoulou, et al.
Published: (2022-01-01)

Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
by: Gibb, D, et al.
Published: (2004)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
by: Mamo A, et al.
Published: (2022-02-01)

Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
by: Portia C Mutevedzi, et al.
Published: (2011-01-01)

Effects of adherence to antiretroviral therapy on body mass index, immunological and virological status of Nigerians living with HIV/AIDS
by: S.A. Olowookere, et al.
Published: (2016-03-01)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia [Corrigendum]
by: Mamo A, et al.
Published: (2022-03-01)

Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques
by: M. Paiardini, et al.
Published: (2015-12-01)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.
by: Miriam Rosás-Umbert, et al.
Published: (2017-01-01)

Predictors of SIV recrudescence following antiretroviral treatment interruption
by: Mykola Pinkevych, et al.
Published: (2019-10-01)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
by: Lorna Leal, et al.
Published: (2020-08-01)

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment
by: E. I. Veselova, et al.
Published: (2020-06-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.
by: David A Wohl, et al.
Published: (2013-01-01)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
by: Katherine E Clarridge, et al.
Published: (2018-01-01)

Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa.
by: Boris Julg, et al.
Published: (2012-01-01)

Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
by: Paris, D, et al.
Published: (1999)

Predictors of Virological Failure in HIV Patients Receiving First Line Antiretroviral Therapy with Good Adherence
by: Farid Kurniawan, et al.
Published: (2017-03-01)

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasilia, Brazil during 2002–2008
by: Edson José Monteiro Bello M.Sc., et al.
Published: (2011-01-01)

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasília, Brazil During 2002–2008
by: Edson José Monteiro Bello, et al.
Published: (2011-11-01)

Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil
by: Janaina Aparecida Schineider Casotti, et al.
Published: (2011-12-01)

Pregnancy and virologic response to antiretroviral therapy in South Africa.
by: Daniel Westreich, et al.
Published: (2011-01-01)

Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity
by: Jonathan B Angel, et al.
Published: (2020-10-01)

Long-Term Immunological and Virological Outcomes in Children Receiving Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia
by: Demissie Assegu Fenta, et al.
Published: (2021-01-01)

Virologic and immunologic responses of patients on highly active antiretroviral therapy in a rural community health centre in Limpopo, South Africa: A retrospective study
by: Aniekan Edet, et al.
Published: (2019-05-01)

Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced brazilian children receiving highly active antiretroviral therapy containing Lopinavir-Ritonavir
by: Daisy Maria Machado, et al.

Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa
by: Sanon Anselme, et al.
Published: (2011-09-01)